Compare · HLF vs MEDS

HLF vs MEDS

Side-by-side comparison of Herbalife Ltd. (HLF) and DataMeds AI Inc. (MEDS): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both HLF and MEDS operate in Other Pharmaceuticals (Health Care), so they compete in similar markets.
  • HLF is the larger of the two at $1.63B, about 391.2x MEDS ($4.2M).
  • HLF has been more active in the news (10 items in the past 4 weeks vs 7 for MEDS).
  • HLF has more recent analyst coverage (14 ratings vs 1 for MEDS).
MetricHLFMEDS
Company
Herbalife Ltd.
DataMeds AI Inc.
Price
-
-
Market cap
$1.63B
$4.2M
1M return
-
-
1Y return
-
-
Industry
Other Pharmaceuticals
Other Pharmaceuticals
Exchange
NYSE
NASDAQ
IPO
2004
News (4w)
10
7
Recent ratings
14
1
HLF

Herbalife Ltd.

Herbalife Nutrition Ltd. offers nutrition solutions in North America, Mexico, South and Central America, Europe, the Middle East, Africa, and the Asia Pacific. The company provides products in the areas of weight management; targeted nutrition; energy, sports, and fitness; and outer nutrition. It offers weight management products, including meal replacement products, protein shakes, drink mixes, weight loss enhancers, and healthy snacks; targeted nutrition products, which include functional beverages, and dietary and nutritional supplements that contain herbs, vitamins, minerals, and other natural ingredients; outer nutrition products, such as facial skin, body, and hair care products; and energy, sports, and fitness products comprising N-R-G tea and energy drink products. The company also provides literature, promotional, and other materials that include start-up kits, sales tools, and educational materials. It offers its products through independent service providers and sales representatives, as well as through company-operated retail platforms. The company was formerly known as Herbalife Ltd. and changed its name to Herbalife Nutrition Ltd. in April 2018. Herbalife Nutrition Ltd. was founded in 1980 and is headquartered in Los Angeles, California.

MEDS

DataMeds AI Inc.

DataMEDS AI, Inc. (NASDAQ:MEDS), formerly Wellgistics Health, Inc., is a healthcare company focused on the vertical integration of technology, pharmacy, pharmaceutical-adjacent and telemedicine business units through its health information technology platforms to deliver a better experience for consumers and providers. Headquartered in Tampa, Fla., DataMEDS incorporates its EinsteinRx artificial intelligence platform and PharmacyChain blockchain-enabled smart contracts platform into the Health Lives Here mobile application from Tollo Health, LLC, and its pharmacy-related Corexa Health subsidiary provides pharmacy dispensing and pharmacy-related services, including distribution of products developed by Tollo Health. DataMEDS also owns Helomics Corporation, a Pittsburgh, PA -based commercial clinical molecular diagnostics laboratory focused on the ChemoFx Assay chemotherapy selection diagnostics test that aims to help oncologists make chemotherapy treatment decisions.

Latest HLF

Latest MEDS